September 08, 2026
Law360 Healthcare Authority looks at a D.C. Circuit decision partially reversing a biotech company's loss, a New York judge's declining to enjoin plans by the U.S. Department of Health and Human Services, and other litigation affecting the healthcare industry.
September 04, 2026
A D.C. Circuit panel said Friday that a proposed Vertex Pharmaceutical program that would offer gene therapy patients financial support for fertility services violates the Anti-Kickback Statute, finding the initiative could be an unlawful inducement to purchase a certain medical treatment.
February 23, 2026
Sharks and moats were top of mind Monday morning for one judge on the D.C. Circuit, as gene therapy drugmaker Vertex Pharmaceuticals attempted to convince the court that its fertility preservation program does not violate the Anti-Kickback Statute.